Coronapod: solving the COVID vaccine manufacturing problem
Nature Podcast
Is Quality Control the Complete Barrier?
Madurna and feiser are on tract to bring in more than 53 billion in revenue this year just from the coved vaccines. They're hopeful that m r and a vaccines can be a platform to make vaccines for all sorts of things like cancer and h i v. So therefore, teaching another company how to make an mrnavaccine compromises their hold on the field. None of the companies i spoke to said, this is why. But this is something that people, you know, point out pretty easily.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
